Four short reports, and the loudest target doubled the same day
Weekly Wrap Up: Sunday, August 9, 2026
Four reports, and the loudest made its noise in the wrong direction. Fugazi Research published on T3 Defense on Monday and the stock closed the day up 122.2%, caught in a squeeze that followed a 125-to-1 reverse split, which is the very thing the report is about. Gotham City Research went to Tokyo the same morning with a ¥116 billion hole in a Sumitomo subsidiary's accounts and barely moved the stock. J Capital and The Bear Cave landed later and hardly registered. Off the tape it was a better week: 2CRSi named the firm that will investigate Grizzly Research's allegations against it.
- Fugazi Research targeted T3 Defense Inc. (DFNS) alleging the company has run the same reverse-split, paper-funded acquisition and dilution playbook twice under two names. Stock closed the week up 37.1%.
- Gotham City Research targeted Sumitomo Chemical Company, Limited (4005.T) alleging an unexplained ¥116 billion gap between the Swiss subsidiary dividend Sumitomo Pharma announced and the one buried in its filing notes. Stock closed the week down 2.3%.
- The Equity Dispatch targeted Weibo Corporation (WB) alleging it may be acting as an undisclosed banker to controlling shareholder Sina, which owes over $1 billion under a Cayman Islands court order. Stock closed the week down 0.1%.
- The Bear Cave targeted Tenable Holdings, Inc. (TENB) alleging AI tools, open-source scanners and platform bundling have commoditized vulnerability management and permanently impaired the company's terminal value. Stock closed the week up 0.6%.
Track every activist short campaign in one place.
The Activ8Insights dashboard gives you searchable access to short reports, researcher profiles, and live stock performance data across the entire activist short selling universe.
Explore the Dashboard →New from Activ8 This Week
|
Situational Awareness, Meet the Short Sellers Leopold Aschenbrenner turned an essay about the physical limits of AI into a $3.85 billion portfolio, then finished July down around 67%. We ran his disclosed holdings against our database and found short reports covering 96.6% of the book, every one of the ten largest positions included. |
|
July 2026 Monthly Short Selling Report Thirteen campaigns averaged -11.4% in July, but the median moved just -2.6%, because one report took Sadot Group down 78.3% and dragged the average with it. Every campaign, every researcher, and what that gap says about how a short report actually lands. |
New Activist Reports
| Metric | Price | Change |
|---|---|---|
| Close (Day Before) | $27.68 | — |
| Low (Report Date) | $40.13 | +45.0% |
| Close (Report Date) | $61.50 | +122.2% |
| Close (End of Week) | $37.95 | +37.1% |
Stock Price Impact
T3 Defense never came near its prior close. The intraday low was already 45.0% above it, and the stock finished the session up 122.2%. That is the low-float squeeze following the July 20 reverse split, not a verdict on the thesis, and the squeeze is itself what Fugazi Research is writing about. The rest of the week ran the other way, closing Friday up 37.1%.
About T3 Defense Inc.
A Nasdaq-listed aerospace and defense acquisition platform, previously Nukkleus Inc. and before that Brilliant Acquisition Corp., renamed on February 9, 2026. It buys operating subsidiaries and funds itself through equity issuance, an Equity Line of Credit and promissory notes. First-quarter revenue was $3.65 million against a $26.35 million net loss and roughly $69 million of negative working capital. CEO Menachem "Menny" Shalom has led it since September 2024.
Key Points from the Report
- The same playbook has now run twice. Fugazi Research documents an 8-to-1 reverse split in October 2024 followed seven weeks later by the Star 26 acquisition announcement, which took the stock from $1.39 to a $52.10 high with short interest near 70% of float, then dilution from 1.18 million shares to 5.31 million. The 2026 cycle repeats it with the paper front-loaded.
- The share count rose roughly 630% in under seven months, from 19.026 million at the end of 2025 to about 139.8 million just before the reverse split. The ratio was disclosed at 50-to-1 on July 13 and upsized to 125-to-1 three days later, without a new shareholder vote.
- The CEO sits across at least eight affiliated entities, including both sides of T3's $69.4 million Star 26 acquisition, which generated $72.3 million of goodwill from a target with negative working capital. T3's own 10-K concedes the roles "may reduce the time and attention he can dedicate to T3."
- A $172.5 million SPAC trust inflates the balance sheet and funds nothing. Consolidation pulls SC II Acquisition Corp.'s trust onto T3's books, yet according to Fugazi Research none of it can service debt or touch the $68.8 million working capital deficit disclosed in the same filing.
Read the Full Report Summary →
| Metric | Price | Change |
|---|---|---|
| Close (Day Before) | ¥521.30 | — |
| Low (Report Date) | ¥503.10 | -3.5% |
| Close (Report Date) | ¥512.60 | -1.7% |
| Close (End of Week) | ¥509.40 | -2.3% |
Stock Price Impact
Tokyo took it calmly. The stock fell 3.5% intraday, recovered more than half of that by the close, and drifted to finish the week down 2.3%. That is muted against a report valuing the shares 50% to 100% lower, though the reason may be structural: Gotham City Research notes the Swiss subsidiary's own annual report will not be public until summer 2028, leaving little a Tokyo investor can check this week.
About Sumitomo Chemical Company, Limited
A Tokyo-listed chemical conglomerate with FY2025 revenue of ¥2,328.5 billion. Its defining feature is a subsidiary: it holds roughly 48% of Sumitomo Pharma and fully consolidates it, and Pharma delivered 92% of Chemical's ¥115.4 billion net income on about a fifth of consolidated revenue. Pharma raised ¥116.4 billion in an April 2026 equity offering. Both are audited by KPMG AZSA LLC, with the Swiss subsidiary SMPS audited separately by KPMG AG.
Key Points from the Report
- A ¥116 billion dividend cannot be located in the accounts. A March 25, 2026 press release announced a ¥48,340 million dividend from Swiss subsidiary SMPS; notes filed May 29 instead disclose a ¥164,526 million in-kind dividend of receivables. Gotham City Research states the difference reconciles nowhere on the income statement, balance sheet or equity statement.
- Receivables grew 5.4 times faster than revenue, up 75.6% against 13.7%, the sharpest in at least a decade. The researcher's field checks found one clinic cutting Latuda purchases by over ¥10 million in three months while the company reported Japanese Latuda sales rising, and wholesalers left with "massive dead stock."
- True leverage is estimated at 6.1 to 10.2 times, against a reported 3.5. Gotham City Research strips out ¥96.6 billion to ¥178.5 billion of non-recurring operating income and adjusts for the 52% minority in Pharma. On its low estimate, Chemical's ¥115.4 billion net income becomes a ¥12.4 billion loss.
- Sumitomo Chemical removed its ¥114 billion guarantee on Pharma's debt before April's equity raise, which the report says transferred credit risk to incoming investors. It also flags that the ¥116.4 billion raised is nearly identical to the ¥116 billion it cannot reconcile.
Read the Full Report Summary →
| Metric | Price | Change |
|---|---|---|
| Close (Day Before) | $7.95 | — |
| Low (Report Date) | $7.86 | -1.1% |
| Close (Report Date) | $7.88 | -0.9% |
| Close (End of Week) | $7.94 | -0.1% |
Stock Price Impact
The quietest chart of the week: the entire weekly range sits inside nine cents, and Friday's session recovered almost all of a 0.9% report-day decline. The thesis is a second-order one, about what a controlling shareholder might do to Weibo rather than what Weibo has done, with no fixed date attached. Reports of that shape tend to move slowly or not at all until the event arrives.
About Weibo Corporation
Weibo runs China's premier microblogging platform and earns almost all of its revenue from advertising. It has been consistently profitable and has paid a dividend since 2023, though revenue, profit and user growth have been effectively flat for years. It is majority-controlled by Sina Corporation, which took itself private in 2021 on terms minority shareholders disputed, and has extended significant loans to Sina as a related party.
Key Points from the Report
- Per the public preview of the report, a Grand Court of the Cayman Islands order requires Sina to pay over $1 billion to dissenting shareholders who objected to its 2021 privatization, which The Equity Dispatch characterizes as a "bum rush" low-ball offer.
- The central concern is that Weibo funds it. The researcher believes Sina may lack the liquid assets to pay and, as controlling shareholder, can compel Weibo to extend further loans or provide cash on unfavourable related-party terms. It expects both.
- A Sina default could force a block of Weibo shares onto the market, since some of Sina's external borrowing is collateralized against its Weibo shareholding.
- The report also calls Weibo's advertising revenue per employee implausible, treating it as reason to view the scale of the loans to Sina with additional caution.
The full report is available to The Equity Dispatch subscribers (subscribe here).
Read the Full Report Summary →
| Metric | Price | Change |
|---|---|---|
| Close (Day Before) | $36.17 | — |
| Low (Report Date) | $34.76 | -3.9% |
| Close (Report Date) | $36.38 | +0.6% |
| Close (End of Week) | $36.38 | +0.6% |
Stock Price Impact
Tenable gave the report a real hearing and then took it back, falling 3.9% intraday before closing up 0.6%. The report landed on Friday, so that close is also the week. The low is the more informative number: buyers absorbed the whole decline within one session, on a thesis about slow structural erosion that offers them no dated event to fear.
About Tenable Holdings, Inc.
A roughly $4 billion cybersecurity company whose core business is vulnerability management, identifying and remediating weaknesses across websites and other digital surfaces. Its enterprise platform is Tenable One, and it recently launched Hexa AI, an agentic tool built in partnership with Anthropic. It competes with Qualys, at about $6.5 billion, and Rapid7, now under $700 million and down roughly 90% from its peak.
Key Points from the Report
- Per the public preview of the report, a salesperson at a multibillion-dollar cybersecurity reseller told The Bear Cave that when he runs CrowdStrike deals he tells clients to "get rid of your Tenable," and predicted: "I think they'll lose 50% to CrowdStrike and SentinelOne."
- Itamar Mizrahi, a former Tenable executive, told the researcher that "some of it is fear, some of it is real. They're slowly going to decline." Two further unnamed former employees said they expect the company to lose business.
- Named investors and CISOs call the category commoditized. Arpan Punyani of Garuda Ventures said the terminal value of Qualys, Tenable and Rapid7 "is permanently impaired"; Tobias Citron of Primary VC said "people just use open-source scanners now." CrowdStrike, Palo Alto Networks and Google, via Wiz, are each bundling the function into broader platforms.
- The Bear Cave had a competing tool vibe-coded to test the claim, and reports that "Untenable" found several vulnerabilities Tenable missed. It notes it did not take on the full Tenable One stack or build a better product overall.
The full report is available to The Bear Cave subscribers (subscribe here).
Read the Full Report Summary →
Campaign Updates
- Gotham City Research published a follow-up on Sumitomo Chemical and Sumitomo Pharma, turning from the Swiss dividend to an undisclosed history behind the CiRA and Dr. Yamanaka relationship.
Activ8 Newswire
The SEC closed its AppLovin investigation, and the stock fell anyway - Regulators ended a year-long inquiry into the AXON engine's advertising data practices without enforcement action, and the shares still dropped as much as 28.7% after hours on a $16.3 million revenue miss. Source: Tech Times
Hunterbrook maps a private prison empire hidden behind 80 LLCs - The McConnell family's LaSalle Corrections runs ICE-funded facilities through nearly 80 opaque LLCs and self-dealing subcontracts, a structure its lawyers use to trap lawsuits over inmate deaths inside individual entities. Source: Hunterbrook Media
2CRSi names an investigator for the Grizzly Research allegations - An independent firm will examine three financial years, the 21 third parties named in the June 18 report and a USD 610 million framework contract, with first findings due in September. Source: TradingView
A Hindenburg target is favourite to run world chess - Timur Turlov, founder of Freedom Holding and subject of Hindenburg Research's 2023 report on its revenue recognition and Russian client flows, leads the FIDE presidential race in a contest his own company sponsors. Source: European Interest
